Table 1 Prevalence of the S. mansoni infections determined by the three diagnostic assays across all study areas. For all test assays; n represents the total number of participants; Pos = number positive; and Prev (95% CI) = prevalence with 95% confidence interval
Study area | Diagnostic assay | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Kato-Katz | PCR | POC-CCAa | POC-CCAb | |||||||||
n | Pos | Prev (95% CI) | n | Pos | Prev (95% CI) | n | Pos | Prev (95% CI) | n | Pos | Prev (95% CI) | |
Tomefa | 63 | 35 | 55.6 (42.5–68.1) | 50 | 25 | 50 (35.5–64.5) | 63 | 57 | 90.5 (80.4–96.4) | 63 | 36 | 57.1 (44–69.5) |
Torgahkope-Adakope | 58 | 5 | 8.6 (2.9–19) | 50 | 4 | 8 (2.2–19.2) | 58 | 51 | 87.9 (76.7–95) | 69 | 8 | 11.6 (5.1–21.6) |
Manheam | 69 | 8 | 11.6 (5.1–21.6) | 60 | 10 | 16.7 (8.3–28.5) | 69 | 56 | 81.2 (69.9–89.6) | 58 | 16 | 27.6 (16.7–40.9) |
Total | 190 | 48 | 25.3 (19.3–32.1) | 160 | 39 | 24.4 (17.9–31.8) | 190 | 164 | 86.3 (80.6–90.9) | 190 | 60 | 31.6 (25–38.7) |